<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37160484</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Childhood rheumatic diseases: bites not only the joint, but also the heart.</ArticleTitle><Pagination><StartPage>2703</StartPage><EndPage>2715</EndPage><MedlinePgn>2703-2715</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06621-9</ELocationID><Abstract><AbstractText>Cardiovascular involvement in juvenile rheumatic diseases is the primary manifestation in paediatric vasculitis and a major organ manifestation in paediatric connective tissue diseases. Though coronary vasculitis is the prototypical manifestation of Kawasaki disease, it can also be seen in patients with polyarteritis nodosa. Pericarditis is the most common manifestation seen in juvenile rheumatic diseases like systemic onset JIA, and lupus. Cardiac tamponade, valvular insufficiency, aortic root dilatation and arrhythmias are seen rarely. Cardiac involvement is often recognized late in children. The development of cardiac disease in juvenile systemic sclerosis is associated with a poor outcome. In long term, childhood onset of rheumatic diseases predisposes to diastolic dysfunction and premature atherosclerosis during adulthood. Key Points &#x2022; Pericarditis is the most common cardiac manifestation in SLE and can lead to tamponade. &#x2022; Conduction defects are common in juvenile mixed connective tissue disease and systemic sclerosis. &#x2022; Pulmonary hypertension is a significant contributor to mortality in juvenile systemic sclerosis. &#x2022; In Kawasaki disease, early treatment can reduce risk of coronary artery aneurysms.</AbstractText><CopyrightInformation>&#xa9; 2023. International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Koshy Nithin</ForeName><Initials>KN</Initials><Identifier Source="ORCID">0000-0002-0781-6884</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Amita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2187-5186</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India. aa.amita@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C543759">Juvenile-onset scleroderma</SupplMeshName><SupplMeshName Type="Disease" UI="C537703">Juvenile systemic scleroderma</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010493" MajorTopicYN="Y">Pericarditis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012595" MajorTopicYN="Y">Scleroderma, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014657" MajorTopicYN="Y">Vasculitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac diseases</Keyword><Keyword MajorTopicYN="N">Cardiovascular manifestations</Keyword><Keyword MajorTopicYN="N">Juvenile</Keyword><Keyword MajorTopicYN="N">Paediatric rheumatology</Keyword><Keyword MajorTopicYN="N">Poor outcome</Keyword><Keyword MajorTopicYN="N">Severe organ manifestation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37160484</ArticleId><ArticleId IdType="pmc">PMC10169151</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06621-9</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06621-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14:683&#x2013;686. doi: 10.1191/0961203305lu2200oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203305lu2200oa</ArticleId><ArticleId IdType="pubmed">16218467</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz T, Diederichsen LP, Lundberg IE, et al. Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open. 2016;2:e000291. doi: 10.1136/rmdopen-2016-000291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2016-000291</ArticleId><ArticleId IdType="pmc">PMC5051430</ArticleId><ArticleId IdType="pubmed">27752355</ArticleId></ArticleIdList></Reference><Reference><Citation>Danda D, Goel R, Joseph G, et al. Clinical course of 602 patients with Takayasu&#x2019;s arteritis: comparison between Childhood-onset versus adult onset disease. Rheumatology (Oxford) 2021;60:2246&#x2013;2255. doi: 10.1093/rheumatology/keaa569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa569</ArticleId><ArticleId IdType="pmc">PMC8599811</ArticleId><ArticleId IdType="pubmed">33179052</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra DP, Aggarwal A, Lawrence A, et al. Pediatric-onset Takayasu&#x2019;s arteritis: clinical features and short-term outcome. Rheumatol Int. 2015;35:1701&#x2013;1706. doi: 10.1007/s00296-015-3272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-015-3272-7</ArticleId><ArticleId IdType="pubmed">25903354</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalapino K, Arkachaisri T, Lucas M, et al. Childhood Onset Systemic Sclerosis: Classification, Clinical and Serologic Features, and Survival in Comparison with Adult Onset Disease. J Rheumatol. 2006;33(5):1004&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">16583463</ArticleId></ArticleIdList></Reference><Reference><Citation>Civieri G, Castaldi B, Martini G, et al. Early detection of ventricular dysfunction in juvenile systemic sclerosis by speckle tracking echocardiography. Rheumatology (Oxford) 2021;60:103&#x2013;107. doi: 10.1093/rheumatology/keaa208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa208</ArticleId><ArticleId IdType="pmc">PMC7785305</ArticleId><ArticleId IdType="pubmed">32572491</ArticleId></ArticleIdList></Reference><Reference><Citation>Sozeri B, Deveci M, Dincel N, Mir S. The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol. 2013;28:471&#x2013;476. doi: 10.1007/s00467-012-2342-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-012-2342-2</ArticleId><ArticleId IdType="pubmed">23135607</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsalou J, Bradley TJ, Silverman ED. Cardiovascular risk in pediatric-onset rheumatological diseases. Arthritis Res Ther. 2013;15:212. doi: 10.1186/ar4212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4212</ArticleId><ArticleId IdType="pmc">PMC3672705</ArticleId><ArticleId IdType="pubmed">23731870</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh AO, Trupin L, Yazdany J, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res. 2010;62:1152&#x2013;1159. doi: 10.1002/acr.20179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20179</ArticleId><ArticleId IdType="pmc">PMC3755501</ArticleId><ArticleId IdType="pubmed">20235215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31:1409&#x2013;1417. doi: 10.1007/s00296-011-1999-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1999-3</ArticleId><ArticleId IdType="pubmed">21800117</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineles D, Valente A, Warren B, et al. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011;20:1187&#x2013;1192. doi: 10.1177/0961203311412096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311412096</ArticleId><ArticleId IdType="pubmed">21768176</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 1993;36:348&#x2013;354. doi: 10.1002/art.1780360310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780360310</ArticleId><ArticleId IdType="pubmed">8452580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Rheumatology (Oxford) 1995;34:866&#x2013;872. doi: 10.1093/rheumatology/34.9.866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/34.9.866</ArticleId><ArticleId IdType="pubmed">7582729</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC, Xiao R, Mercer-Rosa L, et al. Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease. Lupus. 2018;27:2146&#x2013;2154. doi: 10.1177/0961203318804889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318804889</ArticleId><ArticleId IdType="pmc">PMC6207474</ArticleId><ArticleId IdType="pubmed">30318995</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison MJ, Z&#xfc;hlke LJ, Lewandowski LB, Scott C. Pediatric systemic lupus erythematosus patients in South Africa have high prevalence and severity of cardiac and vascular manifestations. Pediatr Rheumatol. 2019;17:76. doi: 10.1186/s12969-019-0382-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-019-0382-x</ArticleId><ArticleId IdType="pmc">PMC6878620</ArticleId><ArticleId IdType="pubmed">31771606</ArticleId></ArticleIdList></Reference><Reference><Citation>Guevara JP, Clark BJ, Athreya BH. Point Prevalence of Cardiac Abnormalities in Children with Systemic Lupus Erythematosus. J Rheumatol. 2001;28(4):854&#x2013;859.</Citation><ArticleIdList><ArticleId IdType="pubmed">11327262</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulay CB, Dans LF. Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus. Pediatr Rheumatol. 2011;9:7. doi: 10.1186/1546-0096-9-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1546-0096-9-7</ArticleId><ArticleId IdType="pmc">PMC3045886</ArticleId><ArticleId IdType="pubmed">21306603</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiro AC, Derbes SJ, Stopa AR, Gedalia A. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis. 1997;56:272&#x2013;274. doi: 10.1136/ard.56.4.272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.56.4.272</ArticleId><ArticleId IdType="pmc">PMC1752359</ArticleId><ArticleId IdType="pubmed">9166002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC, White BR, Elias MD, et al. Echocardiographic Assessment of Diastolic Function in Children with Incident Systemic Lupus Erythematosus. Pediatr Cardiol. 2019;40:1017&#x2013;1025. doi: 10.1007/s00246-019-02107-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-019-02107-1</ArticleId><ArticleId IdType="pmc">PMC7093038</ArticleId><ArticleId IdType="pubmed">31041461</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nal N, Kara N, Akk&#xf6;k N, et al. Cardiac abnormalities in children with systemic lupus erythematosus. Turk J Pediatr. 2003;45:301&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">14768793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and Laboratory Characteristics and Long-Term Outcome of Pediatric Systemic Lupus Erythematosus: A Longitudinal Study. J Pediatr. 2008;152:550&#x2013;556. doi: 10.1016/j.jpeds.2007.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2007.09.019</ArticleId><ArticleId IdType="pubmed">18346514</ArticleId></ArticleIdList></Reference><Reference><Citation>Schanberg LE, Sandborg C, Barnhart HX, et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009;60:1496&#x2013;1507. doi: 10.1002/art.24469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24469</ArticleId><ArticleId IdType="pmc">PMC2770725</ArticleId><ArticleId IdType="pubmed">19404953</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantez S, Gross GJ, MacLusky I, Feldman BM. Cardiac findings in children with juvenile Dermatomyositis at disease presentation. Pediatr Rheumatol. 2017;15:54. doi: 10.1186/s12969-017-0182-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-017-0182-0</ArticleId><ArticleId IdType="pmc">PMC5504613</ArticleId><ArticleId IdType="pubmed">28693511</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz T, Sanner H, Husebye T, et al. Cardiac dysfunction in juvenile dermatomyositis: a case-control study. Ann Rheum Dis. 2011;70:766&#x2013;771. doi: 10.1136/ard.2010.137968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.137968</ArticleId><ArticleId IdType="pubmed">21216816</ArticleId></ArticleIdList></Reference><Reference><Citation>Witczak BN, Schwartz T, Barth Z, et al. Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis&#x2014;a cross-sectional study. Rheumatol Int. 2022;42:1213&#x2013;1220. doi: 10.1007/s00296-021-05071-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-05071-3</ArticleId><ArticleId IdType="pmc">PMC9203373</ArticleId><ArticleId IdType="pubmed">34984516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio-Barros PD, Bortoluzzo AB, Del Rio APT, et al. Clinical and laboratory profile of juvenile-onset systemic sclerosis in a Brazilian cohort. J Scleroderma Relat Disord. 2019;4:43&#x2013;48. doi: 10.1177/2397198318769796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2397198318769796</ArticleId><ArticleId IdType="pmc">PMC8922581</ArticleId><ArticleId IdType="pubmed">35382153</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I, Tyndall A, Zulian F, et al. Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database. Rheumatology (Oxford) 2012;51:1832&#x2013;1837. doi: 10.1093/rheumatology/kes144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kes144</ArticleId><ArticleId IdType="pubmed">22728264</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I, Klotsche J, Kasapcopur O, et al. POS0079 Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement. Results from the juvenile systemic sclerosis inception cohort. Ann Rheum Dis. 2021;80(247):2&#x2013;247. doi: 10.1136/annrheumdis-2021-eular.799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-eular.799</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I, Klotsche J, Torok KS, et al. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort. J Scleroderma Relat Disord. 2019;4:49&#x2013;61. doi: 10.1177/2397198318790494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2397198318790494</ArticleId><ArticleId IdType="pmc">PMC8922583</ArticleId><ArticleId IdType="pubmed">35382144</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowiec A, Dabrowski R, Wozniak J, et al. Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 years prospective observation. Scand J Rheumatol. 2012;41:33&#x2013;38. doi: 10.3109/03009742.2011.609489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2011.609489</ArticleId><ArticleId IdType="pubmed">22103465</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini G, Foeldvari I, Russo R, et al. Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database. Arthritis Rheum. 2006;54:3971&#x2013;3978. doi: 10.1002/art.22207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22207</ArticleId><ArticleId IdType="pubmed">17133611</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo RA, Katsicas MM. Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary center. Pediatr Rheumatol. 2007;5:6. doi: 10.1186/1546-0096-5-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1546-0096-5-6</ArticleId><ArticleId IdType="pmc">PMC1869029</ArticleId><ArticleId IdType="pubmed">17550632</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkowska-Sak L, Gietka P, Gazda A, Ko&#x142;odziejczyk B. Juvenile systemic sclerosis &#x2013; observations of one clinical centre. Reumatologia. 2022;59(6):367&#x2013;372. doi: 10.5114/reum.2021.112350.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2021.112350</ArticleId><ArticleId IdType="pmc">PMC8768038</ArticleId><ArticleId IdType="pubmed">35079180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;E S-A, Catoggio LJ, Maldonado-Cocco JA, et al. Juvenile progressive systemic sclerosis: Clinical and serologic findings. Arthritis Rheum. 1985;28:699&#x2013;702. doi: 10.1002/art.1780280615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780280615</ArticleId><ArticleId IdType="pubmed">3890869</ArticleId></ArticleIdList></Reference><Reference><Citation>Garty BZ, Athreya BH, Wilmott R, et al. Pulmonary functions in children with progressive systemic sclerosis. Pediatrics. 1991;88:1161&#x2013;1167. doi: 10.1542/peds.88.6.1161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.88.6.1161</ArticleId><ArticleId IdType="pubmed">1956732</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartier P, Bonnet D, Fournet J-C, et al. Severe cardiac involvement in children with systemic sclerosis and myositis. J Rheumatol. 2002;29:1767&#x2013;1773.</Citation><ArticleIdList><ArticleId IdType="pubmed">12180742</ArticleId></ArticleIdList></Reference><Reference><Citation>Foeldvari I, Zhavania M, Birdi N, et al. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology (Oxford) 2000;39:556&#x2013;559. doi: 10.1093/rheumatology/39.5.556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/39.5.556</ArticleId><ArticleId IdType="pubmed">10852989</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels H. Course of Mixed Connective Tissue Disease in Children. Ann Med. 1997;29:359&#x2013;364. doi: 10.3109/07853899708999362.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853899708999362</ArticleId><ArticleId IdType="pubmed">9453280</ArticleId></ArticleIdList></Reference><Reference><Citation>Singsen BH, Bernstein BH, Kornreich HK, et al. Mixed connective tissue disease in childhood. J Pediatr. 1977;90:893&#x2013;900. doi: 10.1016/S0022-3476(77)80555-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(77)80555-6</ArticleId><ArticleId IdType="pubmed">300795</ArticleId></ArticleIdList></Reference><Reference><Citation>Mier RJ, Shishov M, Higgins GC, et al. Pediatric-Onset Mixed Connective Tissue Disease. Rheum Dis Clin N Am. 2005;31:483&#x2013;496. doi: 10.1016/j.rdc.2005.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2005.04.002</ArticleId><ArticleId IdType="pubmed">16084320</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkowska-Sak L, Gietka P. Clinical features and outcome of mixed connective tissue disease in developmental age &#x2013; observational study from one center. Reumatologia. 2019;57:315&#x2013;319. doi: 10.5114/reum.2019.91275.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2019.91275</ArticleId><ArticleId IdType="pmc">PMC7091480</ArticleId><ArticleId IdType="pubmed">32226164</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetlevik SO, Flat&#xf8; B, Rygg M, et al. Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis. 2017;76:159&#x2013;165. doi: 10.1136/annrheumdis-2016-209522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-209522</ArticleId><ArticleId IdType="pubmed">27283334</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med. 1980;69:849&#x2013;858. doi: 10.1016/S0002-9343(80)80010-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(80)80010-6</ArticleId><ArticleId IdType="pubmed">7004181</ArticleId></ArticleIdList></Reference><Reference><Citation>Roldan CA, Shively BK, Crawford MH. An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus. N Engl J Med. 1996;335:1424&#x2013;1430. doi: 10.1056/NEJM199611073351903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199611073351903</ArticleId><ArticleId IdType="pubmed">8875919</ArticleId></ArticleIdList></Reference><Reference><Citation>Leszczynski P, Straburzynska-Migaj E, Korczowska I, et al. Cardiac valvular disease in patients with systemic lupus erythematosus Relationship with anticardiolipin antibodies. Clin Rheumatol. 2003;22:405&#x2013;408. doi: 10.1007/s10067-003-0751-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-003-0751-0</ArticleId><ArticleId IdType="pubmed">14677016</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli F, Alcini E, Di Prima MA, et al. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol. 1995;51:117&#x2013;126. doi: 10.1016/0167-5273(95)02357-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5273(95)02357-3</ArticleId><ArticleId IdType="pubmed">8522406</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeggi ET, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. J Am Coll Cardiol. 2002;39:130&#x2013;137. doi: 10.1016/S0735-1097(01)01697-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01697-7</ArticleId><ArticleId IdType="pubmed">11755298</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody&#x2013;Associated Cardiac Manifestations of Neonatal Lupus. Circulation. 2012;126:76&#x2013;82. doi: 10.1161/CIRCULATIONAHA.111.089268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.089268</ArticleId><ArticleId IdType="pmc">PMC3437628</ArticleId><ArticleId IdType="pubmed">22626746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravelli A, Trail L, Ferrari C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients. Arthritis Care Res. 2010;62:63&#x2013;72. doi: 10.1002/acr.20015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20015</ArticleId><ArticleId IdType="pubmed">20191492</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Guo-chun W, Li M, Ning Z. Cardiac Involvement in Adult Polymyositis or Dermatomyositis: A Systematic Review. Clin Cardiol. 2012;35:685&#x2013;691. doi: 10.1002/clc.22026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.22026</ArticleId><ArticleId IdType="pmc">PMC6652370</ArticleId><ArticleId IdType="pubmed">22847365</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt HM, Hutchins GM. The heart and cardiac conduction system in polymyositis-dermatomyositis: A clinicopathologic study of 16 autopsied patients. Am J Cardiol. 1982;50:998&#x2013;1006. doi: 10.1016/0002-9149(82)90408-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(82)90408-8</ArticleId><ArticleId IdType="pubmed">7137049</ArticleId></ArticleIdList></Reference><Reference><Citation>Denbow CE, Lie JT, Tancredi RG, Bunch TW. Cardiac involvement in polymyositis. Arthritis Rheum. 1979;22:1088&#x2013;1092. doi: 10.1002/art.1780221007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780221007</ArticleId><ArticleId IdType="pubmed">486220</ArticleId></ArticleIdList></Reference><Reference><Citation>de Diniz M, FR, Kozu KT, Elias AM, , et al. Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain. Clin Rheumatol. 2021;40:1497&#x2013;1505. doi: 10.1007/s10067-020-05418-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05418-4</ArticleId><ArticleId IdType="pubmed">32989504</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber AM, Mamyrova G, Lachenbruch PA, et al. Early Illness Features Associated With Mortality in the Juvenile Idiopathic Inflammatory Myopathies: Mortality in Juvenile Myositis. Arthritis Care Res. 2014;66:732&#x2013;740. doi: 10.1002/acr.22212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22212</ArticleId><ArticleId IdType="pmc">PMC4646219</ArticleId><ArticleId IdType="pubmed">24151254</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeoglu R, Adrovi&#xe7; A, Oztun&#xe7; F, et al. New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction. Pediatr Cardiol. 2017;38:1686&#x2013;1695. doi: 10.1007/s00246-017-1714-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-017-1714-6</ArticleId><ArticleId IdType="pubmed">28913656</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini G, Vittadello F, Kasap&#xe7;opur &#xd6;, et al. Factors affecting survival in juvenile systemic sclerosis. Rheumatology (Oxford) 2009;48:119&#x2013;122. doi: 10.1093/rheumatology/ken388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken388</ArticleId><ArticleId IdType="pubmed">18854345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungprasert P, Wannarong T, Panichsillapakit T, et al. Cardiac involvement in mixed connective tissue disease: A systematic review. Int J Cardiol. 2014;171:326&#x2013;330. doi: 10.1016/j.ijcard.2013.12.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.12.079</ArticleId><ArticleId IdType="pubmed">24433611</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899&#x2013;909. doi: 10.1002/1529-0131(199905)42:5&lt;899::AID-ANR8&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199905)42:5&lt;899::AID-ANR8&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">10323445</ArticleId></ArticleIdList></Reference><Reference><Citation>Witczak BN, Hetlevik SO, Sanner H, et al. Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study. J Rheumatol. 2019;46:739&#x2013;747. doi: 10.3899/jrheum.180526.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.180526</ArticleId><ArticleId IdType="pubmed">30877222</ArticleId></ArticleIdList></Reference><Reference><Citation>Skagen K, Hetlevik SO, Zamani M, et al. Preclinical Carotid Atherosclerosis in Patients With Juvenile-Onset Mixed Connective Tissue Disease. J Stroke Cerebrovasc Dis. 2019;28:1295&#x2013;1301. doi: 10.1016/j.jstrokecerebrovasdis.2019.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2019.01.027</ArticleId><ArticleId IdType="pubmed">30772156</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow YJ, Chase DS, Lowenstein Schmidt J, et al. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet Part A. 2015;167:296&#x2013;312. doi: 10.1002/ajmg.a.36887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.36887</ArticleId><ArticleId IdType="pmc">PMC4382202</ArticleId><ArticleId IdType="pubmed">25604658</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;nmez HE, Bay&#x131;nd&#x131;r Y, Batu ED. Cardiovascular manifestations of monogenic periodic fever syndromes. Clin Rheumatol. 2023 doi: 10.1007/s10067-023-06504-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-023-06504-z</ArticleId><ArticleId IdType="pubmed">36622520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sener S, Arslanoglu Aydin E, Batu ED. Cardiac involvement and cardiovascular risk factors in pediatric primary systemic vasculitides. Clin Rheumatol. 2022;42:673&#x2013;686. doi: 10.1007/s10067-022-06434-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06434-2</ArticleId><ArticleId IdType="pubmed">36369404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ae R, Makino N, Kosami K, et al. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017&#x2013;2018. J Pediatr. 2020;225(23&#x2013;29):E2. doi: 10.1016/j.jpeds.2020.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.05.034</ArticleId><ArticleId IdType="pubmed">32454114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato K, Sullivan PF, Eveng&#xe5;rd B, Pedersen NL. Chronic Widespread Pain and Its Comorbidities: A Population-Based Study. Arch Intern Med. 2006;166:1649&#x2013;1654. doi: 10.1001/archinte.166.15.1649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.15.1649</ArticleId><ArticleId IdType="pubmed">16908799</ArticleId></ArticleIdList></Reference><Reference><Citation>Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997;131:888&#x2013;893. doi: 10.1016/S0022-3476(97)70038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(97)70038-6</ArticleId><ArticleId IdType="pubmed">9427895</ArticleId></ArticleIdList></Reference><Reference><Citation>Newburger JW, Takahashi M, Burns JC, et al. The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin. N Engl J Med. 1986;315:341&#x2013;347. doi: 10.1056/NEJM198608073150601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198608073150601</ArticleId><ArticleId IdType="pubmed">2426590</ArticleId></ArticleIdList></Reference><Reference><Citation>Furusho K, Nakano H, Shinomiya K, et al. HIGH-dose intravenous gammaglobulin for kawasaki disease. The Lancet. 1984;324:1055&#x2013;1058. doi: 10.1016/S0140-6736(84)91504-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(84)91504-6</ArticleId><ArticleId IdType="pubmed">6209513</ArticleId></ArticleIdList></Reference><Reference><Citation>Uehara R, Belay ED. Epidemiology of Kawasaki Disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79&#x2013;85. doi: 10.2188/jea.JE20110131.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20110131</ArticleId><ArticleId IdType="pmc">PMC3798585</ArticleId><ArticleId IdType="pubmed">22307434</ArticleId></ArticleIdList></Reference><Reference><Citation>Akagi T, Kato H, Inoue O, et al. Valvular heart disease in Kawasaki syndrome: Incidence and natural history. Am Heart J. 1990;120:366&#x2013;372. doi: 10.1016/0002-8703(90)90081-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(90)90081-8</ArticleId><ArticleId IdType="pubmed">2382613</ArticleId></ArticleIdList></Reference><Reference><Citation>Yutani C, Go S, Kamiya T, et al. Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med. 1981;105:470&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">6895017</ArticleId></ArticleIdList></Reference><Reference><Citation>Printz BF, Sleeper LA, Newburger JW, et al. Noncoronary Cardiac Abnormalities Are Associated With Coronary Artery Dilation and With Laboratory Inflammatory Markers in Acute Kawasaki Disease. J Am Coll Cardiol. 2011;57:86&#x2013;92. doi: 10.1016/j.jacc.2010.08.619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.08.619</ArticleId><ArticleId IdType="pmc">PMC3577068</ArticleId><ArticleId IdType="pubmed">21185506</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran AM, Newburger JW, Sanders SP, et al. Abnormal myocardial mechanics in Kawasaki disease: Rapid response to gamma-globulin. Am Heart J. 2000;139:217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">10650293</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki A, Kamiya T, Tsuchiya K, et al. Tricuspid and mitral regurgitation detected by color flow Doppler in the acute phase of Kawasaki disease. Am J Cardiol. 1988;61:386&#x2013;390. doi: 10.1016/0002-9149(88)90950-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(88)90950-2</ArticleId><ArticleId IdType="pubmed">3341217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravekes WJ, Colan SD, Gauvreau K, et al. Aortic root dilation in kawasaki disease. Am J Cardiol. 2001;87:919&#x2013;922. doi: 10.1016/S0002-9149(00)01541-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(00)01541-1</ArticleId><ArticleId IdType="pubmed">11274955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki Disease Shock Syndrome. Pediatrics. 2009;123:e783&#x2013;e789. doi: 10.1542/peds.2008-1871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1871</ArticleId><ArticleId IdType="pmc">PMC2848476</ArticleId><ArticleId IdType="pubmed">19403470</ArticleId></ArticleIdList></Reference><Reference><Citation>Oates-Whitehead RM, Baumer JH, Haines L, et al (2003) Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2021. 10.1002/14651858.CD004000</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544780</ArticleId><ArticleId IdType="pubmed">14584002</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e928&#x2013;e999. doi: 10.1161/CIR.0000000000000484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId><ArticleId IdType="pubmed">28356445</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace CA, French JW, Kahn SJ, Sherry DD. Initial Intravenous Gammaglobulin Treatment Failure in Kawasaki Disease. Pediatrics. 2000;105:e78&#x2013;e78. doi: 10.1542/peds.105.6.e78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.105.6.e78</ArticleId><ArticleId IdType="pubmed">10835091</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet. 2020;395:1607&#x2013;1608. doi: 10.1016/S0140-6736(20)31094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperotto F, Friedman KG, Son MBF, et al. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180:307&#x2013;322. doi: 10.1007/s00431-020-03766-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03766-6</ArticleId><ArticleId IdType="pmc">PMC7429125</ArticleId><ArticleId IdType="pubmed">32803422</ArticleId></ArticleIdList></Reference><Reference><Citation>Otar Yener G, Pa&#xe7; K&#x131;saarslan A, Ulu K, et al. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study. Rheumatol Int. 2022;42:879&#x2013;889. doi: 10.1007/s00296-021-04980-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04980-7</ArticleId><ArticleId IdType="pmc">PMC8421714</ArticleId><ArticleId IdType="pubmed">34491393</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel R, Kumar TS, Danda D, et al. Childhood-onset Takayasu Arteritis &#x2014; Experience from a Tertiary Care Center in South India. J Rheumatol. 2014;41:1183&#x2013;1189. doi: 10.3899/jrheum.131117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.131117</ArticleId><ArticleId IdType="pubmed">24786922</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakar N, Yalcinkaya F, Duzova A, et al. Takayasu Arteritis in Children. J Rheumatol. 2008;35:913&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">18381778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr GS, Hallahan CW, Giordano J, et al. Takayasu Arteritis. Ann Intern Med. 1994;120:919&#x2013;929. doi: 10.7326/0003-4819-120-11-199406010-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-120-11-199406010-00004</ArticleId><ArticleId IdType="pubmed">7909656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolek EC, Kaya Akca U, Sari A, et al. Is Takayasu&#x2019;s arteritis more severe in children? Clin Exp Rheumatol. 2021;39:32&#x2013;38. doi: 10.55563/clinexprheumatol/kr357t.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/kr357t</ArticleId><ArticleId IdType="pubmed">32940211</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol. 1998;66:S85&#x2013;S90. doi: 10.1016/S0167-5273(98)00155-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-5273(98)00155-7</ArticleId><ArticleId IdType="pubmed">9951807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupi-Herrera E, S&#xe1;nchez-Torres G, Marcushamer J, et al. Takayasu&#x2019;s arteritis. Clinical study of 107 cases. Am Heart J. 1977;93:94&#x2013;103. doi: 10.1016/S0002-8703(77)80178-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8703(77)80178-6</ArticleId><ArticleId IdType="pubmed">12655</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Sharma N, Singh S, et al. Takayasu Arteritis in children and young Indians. Int J Cardiol. 2000;75:S153&#x2013;S157. doi: 10.1016/S0167-5273(00)00180-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-5273(00)00180-7</ArticleId><ArticleId IdType="pubmed">10980355</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn D, Thomson PD, Kala U, et al. A review of Takayasu&#x2019;s arteritis in children in Gauteng, South Africa. Pediatr Nephrol. 1998;12:668&#x2013;675. doi: 10.1007/s004670050526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004670050526</ArticleId><ArticleId IdType="pubmed">9811393</ArticleId></ArticleIdList></Reference><Reference><Citation>Talwar KK, Chopra P, Narula J, et al. Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu&#x2019;s disease) &#x2014; a study by endomyocardial biopsy. Int J Cardiol. 1988;21:323&#x2013;334. doi: 10.1016/0167-5273(88)90109-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5273(88)90109-X</ArticleId><ArticleId IdType="pubmed">2906633</ArticleId></ArticleIdList></Reference><Reference><Citation>Talwar KK, Kumar K, Chopra P, et al. Cardiac involvement in nonspecific aortoarteritis (Takayasu&#x2019;s arteritis) Am Heart J. 1991;122:1666&#x2013;1670. doi: 10.1016/0002-8703(91)90285-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(91)90285-P</ArticleId><ArticleId IdType="pubmed">1683519</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels. 1992;7:11&#x2013;17. doi: 10.1007/BF01744538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01744538</ArticleId><ArticleId IdType="pubmed">1360954</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleftheriou D, Varnier G, Dolezalova P, et al. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther. 2015;17:36. doi: 10.1186/s13075-015-0545-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0545-1</ArticleId><ArticleId IdType="pmc">PMC4392477</ArticleId><ArticleId IdType="pubmed">25879697</ArticleId></ArticleIdList></Reference><Reference><Citation>Jales-Neto L, Levy-Neto M, Bonfa E, et al. Juvenile-onset Takayasu arteritis: peculiar vascular involvement and more refractory disease. Scand J Rheumatol. 2010;39:506&#x2013;510. doi: 10.3109/03009741003742730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009741003742730</ArticleId><ArticleId IdType="pubmed">20560810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravelli A, Pedroni E, Perrone S, et al. Aortic valve regurgitation as the presenting sign of Takayasu arteritis. Eur J Pediatr. 1999;158:281&#x2013;283. doi: 10.1007/s004310051072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004310051072</ArticleId><ArticleId IdType="pubmed">10206123</ArticleId></ArticleIdList></Reference><Reference><Citation>Harahsheh AS, Kulkarni A, Becker C, Ross RD. Conditions Mimicking Coarctation of the Aorta. Pediatr Cardiol. 2007;28:385&#x2013;388. doi: 10.1007/s00246-007-0038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-007-0038-3</ArticleId><ArticleId IdType="pubmed">17710354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozen S, Besbas N, Saatci U, Bakkaloglu A. Diagnostic criteria for polyarteritis nodosa in childhood. J Pediatr. 1992;120:206&#x2013;209. doi: 10.1016/S0022-3476(05)80428-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(05)80428-7</ArticleId><ArticleId IdType="pubmed">1346538</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nal N, Kara N, &#xc7;akar N, et al. Cardiac involvement in childhood polyarteritis nodosa. Int J Cardiol. 1997;60:257&#x2013;262. doi: 10.1016/S0167-5273(97)00119-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-5273(97)00119-8</ArticleId><ArticleId IdType="pubmed">9261636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwerina J, Eger G, Englbrecht M, et al. Churg-Strauss Syndrome in Childhood: A Systematic Literature Review and Clinical Comparison with Adult Patients. Semin Arthritis Rheum. 2009;39:108&#x2013;115. doi: 10.1016/j.semarthrit.2008.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2008.05.004</ArticleId><ArticleId IdType="pubmed">18639318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravelli A, Martini A. Juvenile idiopathic arthritis. The Lancet. 2007;369:767&#x2013;778. doi: 10.1016/S0140-6736(07)60363-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60363-8</ArticleId><ArticleId IdType="pubmed">17336654</ArticleId></ArticleIdList></Reference><Reference><Citation>Koca B, Sahin S, Adrovic A, et al. Cardiac involvement in juvenile idiopathic arthritis. Rheumatol Int. 2017;37:137&#x2013;142. doi: 10.1007/s00296-016-3534-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-016-3534-z</ArticleId><ArticleId IdType="pubmed">27417551</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveen R, Jain A, Muhammed H, et al. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities. Rheumatol Int. 2021;41:625&#x2013;631. doi: 10.1007/s00296-020-04763-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04763-6</ArticleId><ArticleId IdType="pubmed">33388903</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg J, Ferraz MB, Pessoa AP, et al. Symptomatic cardiac involvement in juvenile rheumatoid arthritis. Int J Cardiol. 1992;34:57&#x2013;62. doi: 10.1016/0167-5273(92)90082-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5273(92)90082-E</ArticleId><ArticleId IdType="pubmed">1548110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein B, Takahashi M, Hanson V. Cardiac involvement in juvenile rheumatoid arthritis. J Pediatr. 1974;85:313&#x2013;317. doi: 10.1016/S0022-3476(74)80107-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(74)80107-1</ArticleId><ArticleId IdType="pubmed">4431493</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruscitti P, Natoli V, Consolaro A, et al. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still&#x2019;s disease. Rheumatology (Oxford) 2022;61:4124&#x2013;4129. doi: 10.1093/rheumatology/keac027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac027</ArticleId><ArticleId IdType="pmc">PMC9536787</ArticleId><ArticleId IdType="pubmed">35078234</ArticleId></ArticleIdList></Reference><Reference><Citation>Felix A, Delion F, Suzon B, et al. Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study. Pediatr Rheumatol. 2022;20:98. doi: 10.1186/s12969-022-00766-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-022-00766-8</ArticleId><ArticleId IdType="pmc">PMC9668386</ArticleId><ArticleId IdType="pubmed">36384585</ArticleId></ArticleIdList></Reference><Reference><Citation>Neau P-A, El-Jammal T, Javaux C, et al. The Spectrum of Still&#x2019;s Disease: A Comparative Analysis of Phenotypic Forms in a Cohort of 238 Patients. J Clin Med. 2022;11:6703. doi: 10.3390/jcm11226703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11226703</ArticleId><ArticleId IdType="pmc">PMC9697610</ArticleId><ArticleId IdType="pubmed">36431180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharti BB, Kumar S, Kapoor A, et al. Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis. J Postgrad Med. 2004;50:262&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">15623966</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz D, Ocal B, Ertan &#xdc;, et al. Left Ventricular Diastolic Functions in Juvenile Rheumatoid Arthritis. Pediatr Cardiol. 2000;21:374&#x2013;377. doi: 10.1007/s002460010084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002460010084</ArticleId><ArticleId IdType="pubmed">10865017</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkady EAM, Helmy HAR, Mohamed-Hussein AAR. Assessment of cardiac and pulmonary function in children with juvenile idiopathic arthritis. Rheumatol Int. 2012;32:39&#x2013;46. doi: 10.1007/s00296-010-1548-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-010-1548-5</ArticleId><ArticleId IdType="pubmed">20658239</ArticleId></ArticleIdList></Reference><Reference><Citation>Minoia F, Dav&#xec; S, Horne A, et al. Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients: Macrophage Activation Syndrome in Systemic JIA. Arthritis Rheumatol. 2014;66:3160&#x2013;3169. doi: 10.1002/art.38802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38802</ArticleId><ArticleId IdType="pubmed">25077692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lef&#xe8;vre-Utile A, Galeotti C, Kon&#xe9;-Paut I. Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. Joint Bone Spine. 2014;81:257&#x2013;259. doi: 10.1016/j.jbspin.2013.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2013.09.004</ArticleId><ArticleId IdType="pubmed">24793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppertz H-I, Voigt I, M&#xfc;ller-Scholden J, Sandhage K. Cardiac Manifestations in Patients with HLA B27-Associated Juvenile Arthritis. Pediatr Cardiol. 2000;21:141&#x2013;147. doi: 10.1007/s002469910023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002469910023</ArticleId><ArticleId IdType="pubmed">10754085</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamato T, Laxer RM, de Freitas C, et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am J Cardiol. 1995;75:744&#x2013;746. doi: 10.1016/S0002-9149(99)80672-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(99)80672-9</ArticleId><ArticleId IdType="pubmed">7900679</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz M, Dedeoglu R, Akdeniz B, et al. Systolic and Diastolic Cardiac Functions in Juvenile Spondyloarthropathies. JCR J Clin Rheumatol. 2022;28:e175&#x2013;e179. doi: 10.1097/RHU.0000000000001674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000001674</ArticleId><ArticleId IdType="pubmed">33337801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain KS, Gulati R, Satheesh S, Negi VS. Early-onset subclinical cardiovascular damage assessed by non-invasive methods in children with Juvenile Idiopathic Arthritis: analytical cross-sectional study. Rheumatol Int. 2021;41:423&#x2013;429. doi: 10.1007/s00296-020-04689-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04689-z</ArticleId><ArticleId IdType="pubmed">32857280</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlahos AP, Theocharis P, Bechlioulis A, et al. Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res. 2011;63:1736&#x2013;1744. doi: 10.1002/acr.20613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20613</ArticleId><ArticleId IdType="pubmed">21905249</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;akan M, Karada&#x11f; &#x15e;G, Tanatar A, Ayaz NA. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis. Mod Rheumatol. 2020;30:900&#x2013;904. doi: 10.1080/14397595.2019.1660026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14397595.2019.1660026</ArticleId><ArticleId IdType="pubmed">31462146</ArticleId></ArticleIdList></Reference><Reference><Citation>Meneghel A, Martini G, Amigoni A, et al. Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra. Front Pediatr. 2021;8:635080. doi: 10.3389/fped.2020.635080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.635080</ArticleId><ArticleId IdType="pmc">PMC7848179</ArticleId><ArticleId IdType="pubmed">33537271</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zer S, Alehan D, &#xd6;zme S, et al. Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis. Pediatr Cardiol. 1994;15:151&#x2013;153. doi: 10.1007/BF00796329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00796329</ArticleId><ArticleId IdType="pubmed">8047499</ArticleId></ArticleIdList></Reference><Reference><Citation>Burmester GR, Panaccione R, Gordon KB, et al. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn&#x2019;s disease. Ann Rheum Dis. 2013;72:517&#x2013;524. doi: 10.1136/annrheumdis-2011-201244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2011-201244</ArticleId><ArticleId IdType="pmc">PMC3595151</ArticleId><ArticleId IdType="pubmed">22562972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruperto N, Brunner HI, Synoverska O, et al. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. The Lancet. 2021;398:1984&#x2013;1996. doi: 10.1016/S0140-6736(21)01255-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01255-1</ArticleId><ArticleId IdType="pubmed">34767764</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>